Anomer Bio

Venture Round
anomer.bio Biotech & Healthcare London, United Kingdom
Total Funding Undisclosed
Latest Round Undisclosed Venture Round
Last Announced Undisclosed
Investors 3 Backers
Decision Makers 2 Verified

About Anomer Bio

Anomer Bio: Glycan-targeted small molecule drugs to tackle disease at its first layer of interaction

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Venture Round
Global Headquarters London, United Kingdom
Tracked Since Oct 11, 2026

Web & Domain Identity

Official Website anomer.bio
Domain Registered Date Sep 16, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Milestone

    Website domain registered

    anomer.bio

Investors & Backers

3
IndieBio
SOSV
SOSV SF & NY (Fka IndieBio)

Funding History

Venture Round · Undisclosed

Backers: IndieBio, SOSV, SOSV SF & NY (Fka IndieBio)

Undisclosed Source

Founders & Leadership

3

Marcos Burger Ramos

Co-founder and CSO

Work email & phone locked Unlock →

Oliver Pearce

Scientific co-founder and advisor

Work email & phone locked Unlock →

Sophie James

Co-founder and CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts